3. derived from patients with cancer contained significantly more protein (p=0.0067) compared to healthy donors. Phloretin (Dihydronaringenin) Phosphorylation of AKT and ERK1/2 in plasma EVs from both healthy donors and patients with cancer was relatively low compared to levels in cancer cells. Preliminary analysis of total AKT and ERK1/2 levels in plasma EVs from patients with NSCLC before and after sorafenib/metformin treatment (n=12) shows a significant decrease in AKT levels among patients with a favourable treatment response (p<0.005). == Conclusion == Phosphorylation of protein kinases in EVs reflects their phosphorylation in tumour cells. Total AKT protein levels may allow monitoring of kinase inhibitor responses in patients with cancer. Keywords:biomarker, cancer, kinase inhibitor, signalling, plasma Extracellular vesicles (EVs) are nanometre-sized vesicles released by cells into body fluids such as blood and urine. They can be formed in the cytoplasm by inward budding of endosomal membranes and subsequent fusion with the plasma membrane (exosomes), or they can be shed directly from the Rabbit polyclonal to Dynamin-1.Dynamins represent one of the subfamilies of GTP-binding proteins.These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain.Dynamins are associated with microtubules. plasma membrane (microvesicles) (13). Importantly, EVs can be isolated from blood, cerebrospinal fluid (CSF) and urine. Because they contain tumour-derived nucleic acids and proteins, including kinases such as AKT, EGFR (epidermal growth factor receptor) and MET (46), EVs provide a potential biosource for diagnostics (7,8). Kinases are important targets for treatment in patients with cancer (9). However, not all patients respond favourably to kinase inhibitors and most patients acquire drug resistance. Therefore, biomarkers that aid in prediction and real-time monitoring of treatment responses in patients could be of great value (10). The (re-)activation of protein kinases in tumour cells promotes autophosphorylation and has been associated with drug resistance during treatment (1113). A blood-based test providing information on tumour kinase phosphorylation could allow for longitudinal monitoring of drug resistance and personalized treatment strategies. Here we hypothesized that phosphorylation of protein kinases in EVs could serve as a predictive biomarker during treatment with tyrosine kinase inhibitors. == Materials and methods == == Cells Phloretin (Dihydronaringenin) and compounds == H1650 (NCI-H1650; ATCC) and H3255 (NCI-H3255; ATCC) non-small-cell lung cancer (NSCLC) cells were maintained in RPMI-1640 (Lonza Biowhittaker, Verviers, Belgium). The glioma cell lines U87 (U87MG; ATCC) and U87-EGFRvIII (dr. Web Cavenee, Ludwig Cancer Inst., USA) were cultured in DMEM (Lonza Biowhittaker). All cell culture media were supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin and 0.1 mg/ml streptomycin, referred to as complete DMEM. EV-depleted medium was obtained by 2 h ultracentrifugation of serum at 100,000g before use as a medium supplement. Drug treatments were performed with erlotinib (LC Laboratories, Woburn, MA, USA) in DMEM made up of EV-depleted serum. Cell viability was assessed by 2 h incubation with MTT 3-(4,5-dimethylthiazolyl-2)-2,5-diophenyl tetrazolium bromide (Sigma-Aldrich, Zwijndrecht, The Netherlands). == Isolation of EVs == EVs were isolated from plasma or conditioned media as described previously (14). Supernatants from cells, cultured for 32 h in serum-free or with 10% EV-depleted serum, were centrifuged at 500g for 10 min to remove cells. After another centrifugation step at 2,000g for 15 min, the samples were concentrated by retention and collection using 100 kDa cut-off filters (Amicon Ultra-15, Millipore, Amsterdam, The Netherlands) and stored at 20C. The precleared plasma samples were diluted 10-fold in PBS before ultracentrifugation. Centrifugation at 10,000g for 45 min was applied, before EVs were pelleted by ultracentrifugation at 100,000g for 90 min, using a SW32TI rotor (Beckmann Devices, Woerden, The Netherlands). The EV pellet was treated with proteases (0.5 g/L, Trypsin, Lonza Biowhittaker) or erlotinib (10 M) at 37C for 1 h when indicated. Subsequently, EVs were washed in PBS followed by centrifugation at 100,000g for 90 min. All sequential centrifugation actions were performed at 4C. Phloretin (Dihydronaringenin) Pellets were solubilized in M-PER mammalian protein extraction reagent, supplemented with phosphatase and Phloretin (Dihydronaringenin) protease inhibitor cocktails (Pierce, Thermo Scientific, Breda, The Netherlands). == LC-MS/MS analysis == EVs were isolated from 2 impartial cell cultures (10 T175) for each cell line and isolated as described above. Full sample yield (corresponding to 1015 g of protein) was loaded on NuPAGE precast gradient gels, and proteins were separated at 125 V. After electrophoresis, gels were fixed in 50% ethanol made up of 3% phosphoric acid and stained with Coomassie R-250 and washed in Milli-Q water (Supplementary Fig. 1). Gel lanes were.